Back

CLEAR - Outcomes analysis by glycaemic status

26 August 2023 (17:00 - 17:15)
Organised by: Logo
Congress Presentation Part of: Clinical trial updates on prevention and lipid lowering Drug therapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
CLEAR - Outcomes total events analysis
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
OCEAN(a)-DOSE Extension
Doctor M. O'Donoghue (Boston, US)
Slides Video
Presentation thumbnail
DANCAVAS - User-defined outcomes
Professor J. Lindholt (Odense, DK)
Slides Video

Access the full session

Session thumbnail
Clinical trial updates on prevention and lipid lowering
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Is bempedoic acid better than statins to avoid new-onset diabetes?
13 April 2023
thumbnail
Congress Presentation
Red cell distribution width as a predictor of cardiovascular events in high-risk patients with statin intolerance: post-hoc analysis of the CLEAR Outcomes trial
1 September 2024
thumbnail
Congress Presentation
Frequency of gout adverse events with bempedoic acid or placebo in those receiving uric acid lowering therapies as prophylaxis or treatment after a gout episode - insights from CLEAR outcomes
31 August 2025
thumbnail
Congress Presentation
Semaglutide is associated with lower risk of cardiovascular events compared with tirzepatide in patients with overweight or obesity and ASCVD and without diabetes in routine clinical practice
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources